Evidence map›Paper›PMID 36536411›Full record

ArticleJournal of inflammation (London, England)2022

Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts.

Francesca Lombardi, Francesca Rosaria Augello, Serena Artone, Blerina Bahiti, Jenna Marie Sheldon, Maurizio Giuliani, Maria Grazia Cifone, Paola Palumbo, Benedetta Cinque

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. The dual role of the microbiome in chronic wound management.Cell communication and signaling : CCS · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  9. Probiotics in Wound Healing.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Francesca Lombardi *Department of Life, Health and Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building "Rita Levi Montalcini" (Delta 6), 67100, L'Aquila, Italy.
Francesca Rosaria Augello *Department of Life, Health and Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building "Rita Levi Montalcini" (Delta 6), 67100, L'Aquila, Italy.
Serena ArtoneDepartment of Life, Health and Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building "Rita Levi Montalcini" (Delta 6), 67100, L'Aquila, Italy.
Blerina BahitiDepartment of Life, Health and Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building "Rita Levi Montalcini" (Delta 6), 67100, L'Aquila, Italy.
Jenna Marie SheldonDr. Kiran C Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.
Maurizio GiulianiDepartment of Life, Health and Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building "Rita Levi Montalcini" (Delta 6), 67100, L'Aquila, Italy.
Maria Grazia CifoneDepartment of Life, Health and Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building "Rita Levi Montalcini" (Delta 6), 67100, L'Aquila, Italy.
Paola PalumboDepartment of Life, Health and Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building "Rita Levi Montalcini" (Delta 6), 67100, L'Aquila, Italy.
Benedetta CinqueDepartment of Life, Health and Environmental Sciences, University of L'Aquila, Via Pompeo Spennati, Building "Rita Levi Montalcini" (Delta 6), 67100, L'Aquila, Italy. benedetta.cinque@univaq.it.
University of L'Aquila · ITNova Southeastern University · US

Funding

Funding for research by Department of Life, Health & Environmental Sciences, University of L'Aquila FFO MeSVA 2021 and 2022
6 · The paper itself

Abstract

backgroundAbnormal and deregulated skin wound healing associated with prolonged inflammation may result in dermal fibrosis. Since the current therapeutic strategies revealed unsatisfactory, the investigation of alternative approaches such as those based on the use of specific probiotic strains could provide promising therapeutic options. In this study, we aimed to evaluate whether the lysate from S. thermophilus could antagonize the fibrogenic effects of TGF-β1 in normal human dermal fibroblasts (NHDF).

methodsNHDF were exposed to TGF-β1 to establish a fibrotic phenotype. Proliferation rate and cell number were measured using the IncuCyte® Live Cell Imager system and the trypan blue dye exclusion test. Phenoconversion markers (α-SMA and fibronectin) and collagen I levels were assessed by western blot and immunofluorescence. The mRNA levels of TGF-β1 were evaluated by RT-PCR. The Smad2/3 phosphorylation level as well as β-catenin and PPARγ expression, were assessed by western blot. The cell contractility function and migration of NHDF were studied using collagen gel retraction assay, and scratch wound healing assay, respectively. The effects of S. thermophilus lysate, alone or combined with TGF-β1, were evaluated on all of the above-listed parameters and markers associated with TGF-β1-induced fibrotic phenotype.

resultsExposure to the S. thermophilus lysate significantly reduced the key mediators and events involved in the abnormal activation of myofibroblasts by TGF-β1 within the fibrotic profile. The S. thermophilus treatment significantly reduced cell proliferation, migration, and myo-differentiation. In addition, the treatment with probiotic lysate reduced the α-SMA, fibronectin, collagen-I expression levels, and affected the collagen contraction ability of activated dermal fibroblasts. Moreover, the probiotic targeted the TGF-β1 signaling, reducing Smad2/3 activation, TGF-β1 mRNA level, and β-catenin expression through the upregulation of PPARγ.

conclusionThis is the first report showing that S. thermophilus lysate had a remarkable anti-fibrotic effect in TGF-β1-activated NHDF by inhibiting Smad signaling. Notably, the probiotic was able to reduce β-catenin and increase PPARγ levels. The findings support our point that S. thermophilus may help prevent or treat hypertrophic scarring and keloids.

Indexed as

Fibrotic markersPPARγSkin fibrosisSmad signalingS. thermophilusTGF-β1β-catenin

Identifiers

PMID36536411
PMCPMC9764521
OpenAlexW4312093733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.